Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

UTair aircraft passenger traffic in 2023 increased by 9.3%

1/18/24 UTAR

M.Video-Eldorado registers trademark for additional services

1/18/24 MVID

Nornickel and Rosatom additional capitalization of Polar Lithium

1/17/24 GMKN

Rostelecom's revenue in 2023 exceeds ₽700 billion

1/17/24 RTKM

Aeroflot passenger turnover up 25.4% in 2023

1/17/24 AFLT

Novatek in 2023 sold 2.7% more gas

1/17/24 NVTK

Sberbank reported for 2023 by RAS

1/17/24 SBER

VMTP again first in Russia in terms of container turnover

1/17/24 FESH

SFI shareholder redomiciled to Russia

1/16/24 SFIN

Sovcomflot will transport almost 1.7 million tons of hydrocarbons through the NSR in 2023

1/16/24 FLOT